ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Guideline Adherence Improves Early Breast Cancer Survival

August 27, 2004

Seattle Cancer Care Alliance Marks its 10th Anniversary—January 2011

June 28, 2021

Wider Use Of Adjuvant Chemotherapy Recommended By NIH Consensus Panel.

November 10, 2000

Consensus Conference On Receptors Planned

June 22, 1979

Neutron Clinical Trials Contract Concept Approved

June 22, 1984

NCI Issues 8 Awards, 12 Feasibility Grants, In New SPORE Program

October 9, 1992